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Abstract
Background/objectives
It has been suggested that subfertility and testicular cancer share genetic and environmen-
tal risk factors. We studied both subfertility and the strongest known testicular cancer sus-
ceptibility gene, the c-KIT ligand (KITLG), whose pathway is involved in spermatogenesis.
Methods
The EPSAM case-control study is comprised of testicular cancer patients from the Province
of Turin, Italy, diagnosed between 1997 and 2008. The present analysis included 245 cases
and 436 controls from EPSAM, who were aged 20 years or older at diagnosis/recruitment.
The EPSAM questionnaire collected information on factors such as number of children, age
at first attempt to conceive, duration of attempt to conceive, use of assisted reproduction
techniques, physician-assigned diagnosis of infertility, number of siblings, and self-reported
cryptorchidism. Genotyping of the KITLG single nucleotide polymorphism (SNP) rs995030
was performed on the saliva samples of 202 cases and 329 controls.
Results
Testicular cancer was associated with the number of children fathered 5 years before diag-
nosis (odds ratio (OR) per additional child: 0.78, 95% confidence interval (CI): 0.58–1.04)
and sibship size (OR per additional sibling: 0.76, 95% CI: 0.66–0.88). When considering the
reproductive history until 1 year before diagnosis, attempting to conceive for at least 12
months or fathering a child using assisted reproduction techniques was not associated with
the risk of testicular cancer, nor was age at first attempt to conceive or physician-assigned
diagnosis of infertility. The SNP rs995030 was strongly associated with risk of testicular can-
cer (per allele OR: 1.83; 95%CI: 1.26–2.64), but it did not modify the association between
number of children and the risk of testicular cancer.
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Conclusion
This study supports the repeatedly reported inverse association between number of children
and risk of testicular cancer, but it does not find evidence of an association for other indica-
tors of subfertility.
Introduction
Testicular cancer is a relatively rare malignancy and occurs most commonly in young and
middle-aged men [1, 2]. Although the incidence of testicular cancer is low worldwide, over the
last decades it has increased by 3–4% per year in several populations [3]. There are few well-
established risk factors for testicular cancer, including cryptorchidism, contralateral testicular
cancer, family history of testicular cancer, and height [4]. Ninety-five percent of testicular can-
cers are germ cell tumours, which can be subcategorized into seminomas and nonseminomas.
There is a large amount of literature on the association between subfertility and the risk of
testicular cancer. Large register-based studies in the Nordic countries found that men with tes-
ticular cancer fathered fewer children before their diagnosis than did their corresponding con-
trol populations [5–7], and this association has been replicated in other case-control studies
[8–10]. Furthermore, men with testicular cancer tend to have fewer siblings, which might sug-
gest a reduced fertility in their parents [11–13].
The associations between the risk of testicular cancer and other questionnaire-based indica-
tors of infertility (e.g. difficulty impregnating a partner or reported diagnosis of infertility) and
clinical measures of infertility (e.g. sperm count and motility, serum Inhibin B, FSH, and tes-
tosterone) are less consistent and more difficult to investigate than the number of children
fathered, due to problems of reverse causation, measurement errors, and recall and detection
bias. Cohort studies of men evaluated for infertility [14–19] have found an increased risk of
testicular cancer among those with abnormal semen analyses or male-factor infertility. These
studies have the strength of prospective measurements of fertility, often using semen analysis,
but they may be affected by other sources of bias, including confounding by cryptorchidism,
and detection bias. Furthermore, couples seeking medical advice for fertility problems are a
selected sample, whose data might not be comparable with population-based external cancer
incidence data.
Malignancies of the testis have an important inherited component: brothers and sons of
testicular cancer patients have an 8–10 and 4–6 fold increased risk of testicular cancer, respec-
tively [20].
Genome-wide association studies (GWAS) have detected more than twenty loci that are
associated with the risk of testicular cancer [21–28]. Notably, two independent GWAS found
that allele variations in KITLG (the unique ligand for the receptor tyrosine kinase KIT) were
the strongest genetic risk factors for testicular germ cell tumors [21, 22]. These studies showed
that the KITLG single nucleotide polymorphism (SNP) rs995030 was associated with an at least
2-fold increased risk of testicular cancer. The other identified SNPs were in strong linkage dis-
equilibrium with each other and with rs995030 (r2>0.8), which may thus serve as a TagSNP.
Apart from these SNPs, other genetic alterations of the KIT/KITLG pathway have been linked
to an increased susceptibility to testicular germ cell tumors [29–33].
The KIT–KITLG system is also crucial for germ cell survival, proliferation, motility, and
migration [34], and its alterations may impair fertility. Indeed, mutations [35, 36], complete
or partial deletions of KIT or KITLG sequences [37, 38] and altered expression of either genes
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have been reported to be involved in the disruption of normal germ cell development [39, 40],
in increased spermatocyte apoptosis [41], and in microenvironment alterations [42].
A few epidemiological studies found some empirical evidence of an association between
KIT/KITLG SNPs and the risk of male infertility, although the results were not entirely consis-
tent [43–45].
We used data from the EPSAM case-control study, carried out in the North of Italy, to estimate
the role of subfertility in the aetiology of testicular cancers. In order to disentangle the possible
roles of shared environmental and genetic risk factors, we also assessed interactions the KITLG
SNP rs995030 may have with subfertility in its association with the risk of testicular cancer.
Material and Methods
The EPSAM study was approved by the Ethical Committee (IRB) of the San Giovanni Battista
Hospital–CTO/CRF/Maria Adelaide Hospital (Turin, Italy). All individual participants included
in the study signed informed consent forms.
The EPSAM study
The EPSAM case-control study is comprised of patients resident in the Province of Turin,
Italy diagnosed with a histologically-confirmed testicular germ cell tumor between 1997 and
2008 and their controls.
Testicular germ cell cancer cases who underwent an orchiectomy (ICD-9 CM surgical proce-
dure codes: 623–624) for testicular cancer (ICD-9 CM diagnostic code: 186) during the study
period were identified in regional Hospital Discharge Registry. Those patients who were treated
at the Oncology Ward of the San Giovanni Battista Hospital (the main hospital of the city of
Turin) were contacted through their oncologist; patients who were treated at other hospitals
were contacted through their GPs (81% of the contacted GPs with eligible patients agreed to col-
laborate). Histological reports of all cases were consulted to determine the subtype of the germ
cell tumors (seminoma or nonseminoma). One case without histological confirmation was
included in the study on the basis that 95% of testicular tumors are germ cell cancers.
Up to two population-based controls were selected per case: for each case contacted
through his GP, we randomly selected two men from the list of the same GP, matched by year
of birth and residence (Turin or rest of the province of Turin), and for each case contacted
through the San Giovanni Battista Hospital, we contacted up to two patients frequency
matched by birth year and residence among patients admitted at the same hospital for non-
neoplastic diseases that were unrelated to hormonal factors, fertility status, or testicular health.
All cases and controls completed a questionnaire that collected information on age at diag-
nosis, exposures occurring during puberty, adolescence, and early adulthood, as well as on
main risk factors for testicular cancer. This included year of birth, residence, and education
level, as well as detailed information on fertility: number of children, information on each
child fathered, including date of birth, age at first attempt to conceive, duration of attempts to
conceive, use of assisted reproduction techniques, number of months of attempts to conceive
and if they ever visiting a doctor for infertility problems, physician-assigned diagnosis of male-
or female-factor infertility, number of siblings (which was used to calculate sibship size), and
self-reported cryptorchidism. The response proportion was 57% among cases and 48% among
controls.
Cases and controls were also asked to self-collect and mail a saliva sample using the Ora-
gene DNA (OG-250) Collection Kit (DNA Genotek Inc., Ottawa, Canada), with a response
proportion of 84% among both cases and controls.
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Full details of the EPSAM study design have been described in previous publications [46,
47]. Anonymized data on fertility status and genotyping of cases and controls are available
upon request to qualified researchers for the purpose of academic, non-commercial research.
Study sample
For the purposes of this analyses, we restricted the study sample to participants born in Italy
(5 cases and 6 controls excluded) and aged at least 20 years at diagnoses/recruitment (15 cases
and 31 controls excluded), as it is unlikely that attempts to conceive happen before this age.
This left 245 cases 436 controls in the analytical sample. Genotyping of the KITLG single
nucleotide polymorphism (SNP) rs995030 was performed on the saliva samples of 202 cases
and 342 controls.
Molecular analyses
DNA was extracted from 1 ml of saliva using the Oragene Purifier solution (OG-L2P) follow-
ing manufacturer’s protocol. The β-globin gene fragment (268 bp) was amplified by PCR
using previously published conditions [48] and analyzed in 2% agarose-gel electrophoresis.
One case and 15 controls were excluded from genotyping due to DNA inadequacy.
Genotyping of the SNP rs995030 within the 3’UTR of the KITLG gene (Chromosome 12,
NCBI Nucleotide Reference Sequence: NG_012098.1) was performed. Primers, designed using
the PyroMark Assay Design software version 2.0 (Qiagen, Hilden, Germany) were: 5’-ACTG
TGAAACTGGCACTGAATTAA-3’ (forward), 5’-BIOT-CTTGCAGAGACCAGGATAACTAC
A-3’ (reverse), 5’-CGTGTCTCAGACTGCAT-3’(sequencing). PCR was carried out in a
final volume of 35 μl containing 20 ng of genomic DNA, 1X PCR Gold Buffer, 1.5 mM MgCl2
(Applied Biosystems, Foster City, CA), 0.8 mM dNTPs mix (Promega, Madison, WI, USA),
0.5 μmol of each amplification primer (Sigma Aldrich, St. Louis, MO, USA) and 0.05 U of
AmpliTaq Gold DNA polymerase (Applied Biosystems). The PCR termic profile was: denatur-
ation at 95˚C (10 min) followed by 45 cycles of 95˚C (30 s), 60˚C (1 min), 72˚C (1 min), and a
final extension step at 72˚C (10 min). Pyrosequencing analysis was performed onto a Pyro-
Mark Q24 MDx Pyrosequencing System (Qiagen).
Statistical analyses
Information on fertility from questionnaires was used to create indicators of fertility. First, we
analyzed the number of children fathered by cases and controls before diagnosis of testicular
cancer (for controls a reference age was randomly assigned on the basis of the age distribution
at diagnosis of the cases). We then analyzed the age at first attempt to conceive, irrespective of
its success. This is a potential confounder of the association between number of children and
risk of testicular cancer, because earlier age at first attempt gives more opportunities to con-
ceive in analyses that are restricted to the period before cancer diagnosis, and thus cannot
cover the entire reproductive period, and because fertility declines with age. As a more direct
assessment, we also constructed a combined indicator of fertility based on the duration of
attempts to conceive for men whose attempts were successful and for those whose attempts
were not: (1) had children without attempting to conceive or after attempting for less than 12
months; (2) did not have children and did not attempt to conceive; (3) attempted to conceive
for at least 12 months and had/did not have children or had children using assisted reproduc-
tion techniques.
When calculating the number of children fathered, we introduced lag-times before testicu-
lar cancer diagnosis (reference age for controls) of 1 year and 5 years to increase the study’s
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comparability with other studies. For the other indicators of fertility we used a lag-time of 1
year.
We used unconditional logistic regression to estimate odds ratios (ORs) with correspond-
ing 95% confidence intervals (CIs) of testicular cancer, adjusting for matching variables–year
of birth, residence (city of Turin, rest of the Province of Turin), method of recruitment (GPs
or hospital oncologist)–as well as for age at diagnosis/reference age, educational level (junior
high school, high school, university degree), and cryptorchidism. Analyses on age at first
attempt to conceive were restricted to cases and controls who attempted to conceive before the
diagnosis of testicular cancer or the reference age for controls.
We performed sensitivity analyses to check for possible biases in the analyses on fertility.
First, we restricted the analysis to subjects who did not report cryptorchidism, and second to
cases and controls aged at least 35, who have a more complete reproductive history.
For the analyses on the KITLG SNP rs995030, we first tested for the Hardy-Weinberg equi-
librium (HWE) among controls. We used unconditional logistic regression to estimate the OR
of testicular cancer for each genotype according to the codominant model, as well as the OR
for each allele according to an additive model.
We also performed stratified analyses by histological subtype (seminoma or nonseminoma
histology). Stata software version 12.0 (Stata Corporation, College Station, Texas) was used for
the analyses.
Results
Characteristics of the 245 testicular cancer cases and 436 controls included in this study are
summarized in Table 1. Cases and controls had similar educational levels while cryptorchidism
was, as expected, more frequent among cases. Of the 245 cases, 136 had seminoma and 108
had nonseminoma histology.
As reported in Table 2, we observed an inverse association with risk of testicular cancer for
number of children fathered by testicular cancer cases, although CIs were large (OR: 0.78, 95%
CI: 0.58–1.04, per child when a 5-year lag-time was considered). Sibship size of the cases was
also inversely associated with risk of testicular cancer (OR: 0.76, 95% CI: 0.66–0.88, per sib-
ling). Age at first attempt to conceive was not associated with the risk of testicular cancer, and
remarkably, there was no evidence of an association between our combined indicator of fertil-
ity (based on time to conception and use of assisted reproduction techniques) and risk of tes-
ticular cancer.
14 cases and 15 controls reported having visited a doctor for infertility problems up to 1
year before diagnosis/recruitment. After adjustment for cryptorchidism this rendered an OR
of 1.32 (95% CI: 0.59–2.93), which increased to 1.88 (95% CI: 0.35–7.31) when the exposure
was restricted to those reporting a physician-assigned diagnosis of infertility (11 cases and 11
controls) (data not shown). Adjustment for KITLG genotype did not substantially change
these estimates (data not shown).
Restriction to patients without cryptorchidism and to patients diagnosed after 35 years of
age altered the findings only marginally (data not shown). There was no substantial heterogene-
ity between the two histological subtypes, although the statistical power of the estimates was
quite modest. Only when we considered the combined indicator of fertility and age at first
attempt to conceive we observed different estimates and an opposite effect in the two histologi-
cal subtypes; however the statistical power of these results was too weak to draw clear conclu-
sions (See Supporting information, S1 and S2 Tables). We also tested the p-value for interaction
between fertility indicators and histological type and we did not find evidence of heterogeneity
between seminoma and nonseminoma (See Supporting information, S3 Table).
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Among subjects with saliva samples, genotyping of rs995030 was successful in 202 cases
and 333 controls (genotyping success rate: 98.7%); there was no evidence of departure from
HWE (p = 0.10) among controls. Homozygous status for the risk allele (CC) was associated
with an OR of testicular cancer of 5.38 (95% CI 1.21–23.91), compared with the homozygous
status for the non-risk minor allele (TT). Additive analyses revealed an OR of 1.83 (95% CI
1.26–2.64) per 1-copy increase of the C allele (Table 3).
The association between number of children fathered before diagnosis/reference age and
risk of testicular cancer was not modified by KITLG genotype, categorised as CC vs. TT/CT
(Table 4). Similarly, no evidence of effect modification was found for the combined indica-
tor of fertility status (data not shown). Last, we performed the analyses, restricted to control
subjects, on the association between the KITLG genotype and the measures of subfertility
collected. We did not find evidence of an association for number of children fathered 1 year
and 5 year before diagnosis/reference date, age at first attempt of having children and for
sibship size, although an indication of an association between KITLG genotype (CC vs CT/
TT) and attempting to conceive for at least 12 months or fathering a child using assisted
reproduction techniques, compared with attempting to conceive for less than 12 months
before having a child, could be noted (unadjusted OR: 2.75, 95% CI: 0.89–8.53) (data not
shown in Tables).
Table 1. Selected characteristics of cases and controls.
Characteristic Cases (N = 245) Controls (N = 436)
N (%) N (%)
Year of birth
<1960 47 19.2 101 23.2
1960–69 80 32.6 140 32.1
1970–79 100 40.8 165 37.8
1980+ 18 7.4 30 6.9
Method of recruitment
General Practitioners 163 66.5 300 68.8
Hospital 82 33.5 136 31.2
Residence
City of Turin 95 38.8 189 43.3
Province of Turin 150 61.2 247 56.7
Education level
Junior high school 90 36.7 154 35.4
High school 98 40.0 190 43.7
University degree 57 23.3 91 20.9
Missing 0 1
Cryptorchidisma
No 203 87.9 401 96.9
Yes 28 12.1 13 3.1
Missing 14 22
Histology
Seminoma 136 55.7 -
Nonseminoma 108 44.2 -
Missing 1 -
a Self-reported physician-diagnosed cryptorchidism.
doi:10.1371/journal.pone.0169174.t001
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Table 2. Association between indicators of fertility and risk of testicular cancer.
N˚ of cases
(%)
N˚ of controls
(%)
OR1a 95% CIa OR2a 95% CIa
Number of children 1 year before diagnosis/reference date
0 146 (63.8) 242 (59.5) 1.00 Ref 1.00 Ref
1 47 (20.5) 77 (18.9) 1.05 0.66-1-
67
1.10 0.68–
1.77
2 36 (15.7) 88 (21.6) 0.74 0.43–
1.27
0.79 0.46–
1.37
Missing 2 6
Unit increase 0.85 0.66–
1.09
0.88 0.68–
1.13
Number of children 5 years before diagnosis/reference date
0 169 (73.8) 274 (67.3) 1.00 Ref 1.00 Ref
1 36 (15.7) 64 (15.7) 0.91 0.54–
1.52
0.95 0.56–
1.61
2 24 (10.5) 69 (17.0) 0.56 0.30–
1.04
0.63 0.33–
1.18
Missing 2 6
Unit increase 0.74 0.55–
0.98
0.78 0.58–
1.04
Age at first attempt to conceive (years)b
<25 11 (19.0) 18 (18.4) 0.88 0.35–
2.21
0.89 0.35–
2.22
25–29 29 (50.0) 43 (43.9) 1.00 Ref 1.00 Ref
30–34 15 (25.9) 33 (33.7) 0.63 0.28–
1.43
0.54 0.23–
1.26
35 3 (5.2) 4 (4.1) 0.84 0.16–
4.40
0.86 0.16–
4.53
Unit increase 0.98 0.89–
1.06
0.97 0.89–
1.06
Combined indicator of fertility (1 year before diagnosis/reference date)
Had children without attempting to conceive or attempting for less than 12 months 71 (31.6) 146 (37.0) 1.00 Ref 1.00 Ref
Did not have children and did not attempt to conceive 135 (60.0) 220 (55.7) 1.11 0.71–
1.73
1.06 0.68–
1.67
Attempted to conceive for at least 12 months and had or had not children, or had
children using assisted reproduction techniques
19 (8.4) 29 (7.3) 1.28 0.67–
2.45
1.04 0.53–
2.05
Missing 6 18
Sibship size
1 59 (25.8) 74 (18.2) 1.00 Ref 1.00 Ref
2 105 (45.8) 174 (42.9) 0.71 0.46–
1.09
0.72 0.46–
1.11
3 65 (28.4) 158 (38.9) 0.52 0.33–
0.83
0.54 0.34–
0.86
Missing 2 7
Unit increase 0.75 0.65–
0.87
0.76 0.66–
0.88
a Adjusted for year of birth, residence (city of Turin, rest of the Province of Turin), method of recruitment (General Practitioners or hospital), age at diagnosis
or reference age for controls, and educational level (junior high school, high school, university degree)
OR2 adjusted as OR1 and for cryptorchidism
b Restricted to cases and controls who tried to have children at least 5 years before diagnosis or reference age for controls
OR, odds ratio; CI, confidence interval; Ref, reference
doi:10.1371/journal.pone.0169174.t002
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Discussion
We used data from the EPSAM case-control study to explore the relation between subfertility
and the risk of testicular cancer using questionnaire information on fecundity (i.e. number of
children) and a combined indicator of fertility. We found an inverse association between the
number of children fathered before cancer diagnosis and risk of testicular cancer, which was
not explained by age at first attempt to conceive, as this variable was similar among cases and
controls. Sibship size was inversely associated with the risk of testicular cancer. Conversely, we
did not find an association between our combined indicator of fertility and risk of testicular
cancer, although this indicator took into account at the same duration of attempt to conceive,
unexpected pregnancies, and use of assisted reproduction techniques.
The association between fertility and testicular cancer has been investigated in a large num-
ber of studies. Number of children has consistently been reported to be associated with a
decreased risk of testicular cancer both in questionnaire-based case-control studies [8–10] and
in registry-based studies [5–7]. This association typically remains when analyses take into
account socioeconomic factors or history of cryptorchidism, as in our study. Sibship size has
also been repeatedly associated with a decreased risk of testicular cancer [11, 13].
Although our study is consistent with previous studies concerning number of children, we
found no association between a combined indicator of fertility and risk of testicular cancer. If
subfertility was actually associated with the development of testicular cancer, we would have
expected to find a longer duration of attempt to conceive and/or an increased use of assisted
reproduction techniques among cases compared to controls, but this was not observed.
Overall results from case-control studies using self-reported indicators of subfertility other
than fecundity provide a conflicting picture [9, 10, 49–52]. Firstly, these studies are strongly
heterogeneous: they used different indicators of subfertility and different, if any, lag-times
Table 3. Association between the KITLG SNP rs995030 and testicular cancer.
Genetic model Genotype or Allele Cases (N = 202) (%) Controls (N = 342) (%) ORa 95% CIa
Codominant TT 2 (1.0) 15 (4.5) 1.00 Ref
CT 39 (19.3) 91 (27.3) 3.22 0.70–14.80
CC 161 (79.7) 227 (68.2) 5.38 1.21–23.91
Missing 0 9
Additive (per allele) C 1.83 1.26–2.64
a Adjusted for year of birth, residence (city of Turin, rest of the Province of Turin), and method of recruitment
OR, odds ratio; CI, confidence interval; Ref, reference
doi:10.1371/journal.pone.0169174.t003
Table 4. Assessment of effect modification of KITLG on number of children fathered.
Number of children 5 years before diagnosis
Genotype ORa 95% CIa
CT/TT 0.76 0.46–1.26
CC 0.74 0.53–1.02
a Adjusted for year of birth, residence (city of Turin, rest of the Province of Turin), method of recruitment
(GPs or hospital), age at diagnosis or reference age for controls, educational level (junior high school, high
school, university degree), and cryptorchidism.
OR, odds ratio, CI, confidence interval.
doi:10.1371/journal.pone.0169174.t004
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between the age at assessment of the indicator and cancer diagnosis, and only some of them
presented estimates adjusted for cryptorchidism. Indeed, most studies found that fertility
problems are more frequent in cases than controls, but the magnitude of the estimates varied
strongly and it was often impossible to exclude the possibility that reverse causation and/or
confounding by cryptorchidism explained the reported effects.
Cohort studies with information on prospectively-obtained semen parameters have consis-
tently found an association between impaired semen quality and risk of testicular cancer [14–
19]. When the lag-time between semen analysis and cancer diagnosis was considered, the risk
of testicular cancer seemed to be especially increased in the same year or in the year after
semen analysis [5, 15], although it was also evident for longer lag times, indicating that the
association was affected by reverse causation and/or detection bias to a certain extent. It is
noteworthy that the magnitude of the associations was not dramatically large, and it is unclear
if it could explain the inverse association between number of children fathered and risk of tes-
ticular cancer.
Overall, considering the evidence from register-based, case-control and cohort studies, it
seems that the consistent, inverse associations between risk of testicular cancer and number of
children and sibship size are not entirely paralleled or supported by the results of studies that
tried to obtain more direct measurements of fertility.
Since heredity plays a strong role in testicular cancer, we performed genetic analyses to take
this component into account. We did not test our samples for the gr/gr microdeletion on the Y
chromosome, which is largely associated with impaired spermatogenesis [53–55] and the risk
of testicular tumors [56] because it is a rare, low-penetrance allele (carrier frequency 2–3%)
and thus accounts for a limited number of cases. The rs995030 SNP of the KITLG gene, which
has been highly and consistently associated with risk of testicular cancer [21, 22, 45, 57] and is
in strong linkage disequilibrium (r2>0.8) with other susceptibility SNPs [20, 22, 57] was
selected for the present analyses.
Our results give further support to the existence of a strong link between KITLG and the
risk of testicular cancer, but the variant that we analyzed did not modify the association
between the number of children and the risk of testicular cancer, thus sustaining the conclu-
sion of a previous study, which was based on a different indicator of male fertility, i.e. total
sperm count [45].
Although our study has the strength of using multiple indicators to assess fertility, it has
also some relevant limitations. First, our response rate was low, even if it was in line with most
previous studies on testicular cancer. It should be noted, however, that our results on well-rec-
ognized risk factors for testicular cancer (including cryptorchidism and sibship size), are con-
sistent with the literature. Although it is possible that non-response was driven particularly by
fertility status, the lack of evidence of non-response bias for recognized risk factors is reassur-
ing. Second, our analyses are based on self-reported information, with no clinical data available
to confirm fertility status. However, this is unavoidable in case-control studies when a lag-time
between fertility assessment and the diagnosis of testicular cancer is considered. Even in cohort
studies the prospective collection of semen samples is feasible only in specific subgroups of the
population (e.g. subjects with fertility problems, semen donors, etc. . .). Furthermore, the self-
reported number of children fathered by a man is a crude indicator of fertility status. However,
we think that any misclassification that could have been introduced by this indicator would be
non-differential between cases and controls. Finally, some of the associations in our study had
large CIs; thus, although we can draw conclusions as to the direction of the associations and
the overall consistency, inference based on the single estimates should be carried out with
caution.
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Conclusions
Our study supports previously reported inverse associations between testicular cancer and
number of children and sibship size. However, our findings did not reveal an association
between duration of attempt to conceive or use of assisted reproduction techniques and subse-
quent incidence of testicular cancer. The role of infertility, and the involved mechanisms, in
testicular carcinogenesis remains to be elucidated.
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